These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 183787)

  • 1. Protecting action of aspartate on the hepatic changes induced by D-galactosamine.
    Fodor O; Schvartz M; Suciu A; Barbarino F; Duca S; Lezeu R
    Arzneimittelforschung; 1976; 26(5):855-8. PubMed ID: 183787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic studies in experimental liver disease resulting from D(+)-galactosamine administration.
    Record CO; Alberti KG; Williamson DH
    Biochem J; 1972 Nov; 130(1):37-44. PubMed ID: 4655444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The action of silymarin on Galactosamine-induced hepatitis in the rat (author's transl)].
    Barbarino F; Suciu A; Cotutiu C; Ban A
    Wien Klin Wochenschr; 1977 Feb; 89(3):90-5. PubMed ID: 189515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolism of the isolated perfused rat liver following in vitro irradiation. Lactate, glucose, potassium, sodium, chloride as well as GOT and GPT activity in perfusion plasma].
    Stähler F; Sinn I
    Strahlentherapie; 1970 Apr; 139(4):496-505. PubMed ID: 5510087
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of glucagon on carbohydrate synthesis and enzyme activity in rat liver.
    Eisenstein AB; Strack I
    Endocrinology; 1968 Dec; 83(6):1337-48. PubMed ID: 4301834
    [No Abstract]   [Full Text] [Related]  

  • 6. [Histoenzymatic changes under the protective and therapeutic action of aspartic acid in experimental toxic hepatitis].
    Barbarino F; Fodor O; Tăpălagă D; Cotuţiu C; Streja D
    Stud Cercet Med Interna; 1967; 8(6):525-33. PubMed ID: 4229571
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective action of the aspartic acid on liver steroid dehydrogenases in experimental chronic intoxication with carbon tetrachloride.
    Fodor O; Tapalaga D; Barbarino F
    Acta Gastroenterol Belg; 1971 Jun; 34(6):447-54. PubMed ID: 4339659
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatobiliary clearance of labelled mebrofenin in normal and D-galactosamine HCl-induced hepatitis rats and the protective effect of turmeric extract.
    Deshpande UR; Joseph LJ; Samuel AM
    Indian J Physiol Pharmacol; 2003 Jul; 47(3):332-6. PubMed ID: 14723320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of gluconeogenesis in the liver of vitamin B1-deficient rats].
    Maglysh SS; Gorbach ZV; Konovalenko OV
    Biokhimiia; 1990 Aug; 55(8):1491-7. PubMed ID: 2288988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dietary protein on hydrocortisone-mediated adaptive enzymatic changes in rat liver.
    Hurvitz AI; Freedland RA
    Arch Biochem Biophys; 1968 Sep; 127(1):548-55. PubMed ID: 4386972
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of the liver protecting compound ES 914 on D-galactosamine induced experimental hepatitis in the rat].
    Wegmann A; Chariatte N; Renker H; Dittrich A
    Arzneimittelforschung; 1979; 29(1):68-70. PubMed ID: 582121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention by ethyl alcohol of hepatic lesions induced by allyl formate].
    Schwarzmann V; Infante R; Petit D; Berthaux N
    Rev Fr Etud Clin Biol; 1969 Dec; 14(10):1014-7. PubMed ID: 5377888
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical changes induced by ethyl acetate in blood and liver of rat.
    Seth PK; Srivastava SP
    Bull Environ Contam Toxicol; 1974 Nov; 12(5):612-6. PubMed ID: 4373106
    [No Abstract]   [Full Text] [Related]  

  • 15. [The anti-hepatotoxic effect of parenterally administered silymarin in galactosamine hepatitis of the rat].
    Schriewer H; Rausen HM
    Arzneimittelforschung; 1973 Jan; 23():Suppl:159. PubMed ID: 4740687
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of D-penicillamine on the galactosamine hepatitis model in the rat].
    Habersang S; Kozlik V; Leuschner F; von Schlichtegroll A
    Arzneimittelforschung; 1973 Jan; 23(1):56-7. PubMed ID: 4740696
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatoprotective effect of silymarin (carsil) on liver of D-galactosamine treated rats. Biochemical and morphological investigations.
    Tyutyulkova N; Tuneva S; Gorantcheva U; Tanev G; Zhivkov V; Chelibonova-Lorer H; Bozhkov S
    Methods Find Exp Clin Pharmacol; 1981; 3(2):71-7. PubMed ID: 7230979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gluconeogenesis and the factors that control the process in chickens.
    Sarkar NK
    Life Sci II; 1971 Mar; 10(5):293-300. PubMed ID: 4325055
    [No Abstract]   [Full Text] [Related]  

  • 19. [Liver metabolism during massive hemorrhage and subsequent blood transfusion].
    Skovronskaia EV
    Vopr Med Khim; 1978; 24(1):22-8. PubMed ID: 149425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of nicotinamide, tryptophan, and methionine upon galactosamine-induced effects in the liver.
    Kröger H; Grätz R; Museteanu C; Haase J
    Arzneimittelforschung; 1981; 31(6):987-93. PubMed ID: 6455126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.